![Bernard Cambou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernard Cambou
Nessuna posizione attualmente
Storia della carriera di Bernard Cambou
Precedenti posizioni note di Bernard Cambou
Società | Posizione | Inizio | Fine |
---|---|---|---|
Cytomics Pharmaceuticals SA
![]() Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Presidente | - | 09/11/2009 |
Direttore Tecnico/Scientifico/R&S | - | 10/10/2011 | |
Presidente | - | 10/10/2011 | |
Cellatope Corp.
![]() Cellatope Corp. Pharmaceuticals: MajorHealth Technology Cellatope Corp. provides medical services. It develops research & diagnostic products and services for autoimmune diseases focusing on lupus. The company was founded by Alumna Valerie Pajak Glyptis in October, 2004 and is headquartered in Pittsburgh, PA. | Presidente | - | 01/12/2006 |
Birchmere Ventures, Inc.
![]() Birchmere Ventures, Inc. Investment ManagersFinance Birchmere Ventures Inc (Birchmere Ventures) is a venture capital firm founded in the year 1996 by Ned Renzi and Sean Sebastian. The firm is headquartered in Pittsburgh, Pennsylvania with an additional office in San Francisco. | Direttore degli Investimenti | 27/05/2004 | 20/06/2005 |
Analista di Private Equity | 27/05/2004 | 20/06/2005 | |
Investitore di Private Equity | 27/05/2004 | 20/06/2005 | |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | 01/05/2004 |
Pharmacia Corp.
![]() Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | - | 01/05/2004 |
Aventis Behring | Corporate Officer/Principal | - | 01/05/2004 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - | - |
Formazione di Bernard Cambou
Université de Technologie de Compiègne | Doctorate Degree |
ESSEC Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Francia | 4 |
Posizioni
Corporate Officer/Principal | 4 |
President | 2 |
Chief Investment Officer | 1 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Cellatope Corp.
![]() Cellatope Corp. Pharmaceuticals: MajorHealth Technology Cellatope Corp. provides medical services. It develops research & diagnostic products and services for autoimmune diseases focusing on lupus. The company was founded by Alumna Valerie Pajak Glyptis in October, 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Pharmacia Corp.
![]() Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Aventis Behring | Health Technology |
Birchmere Ventures, Inc.
![]() Birchmere Ventures, Inc. Investment ManagersFinance Birchmere Ventures Inc (Birchmere Ventures) is a venture capital firm founded in the year 1996 by Ned Renzi and Sean Sebastian. The firm is headquartered in Pittsburgh, Pennsylvania with an additional office in San Francisco. | Finance |
Cytomics Pharmaceuticals SA
![]() Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
- Borsa valori
- Insiders
- Bernard Cambou
- Esperienza